Highlighting Clinical Metagenomics for Enhanced Diagnostic Decision-making: A Step Towards Wider Implementation

Abstract

Clinical metagenomics (CMg) is the discipline that refers to the sequencing of all nucleic acid material present within a clinical specimen with the intent to recover clinically relevant microbial information. From a diagnostic perspective, next-generation sequencing (NGS) offers the ability to rapidly identify putative pathogens and predict their antimicrobial resistance profiles to optimize targeted treatment regimens. Since the introduction of metagenomics nearly a decade ago, numerous reports have described successful applications in an increasing variety of biological specimens, such as respiratory secretions, cerebrospinal fluid, stool, blood and tissue. Considerable advancements in sequencing and computational technologies in recent years have made CMg a promising tool in clinical microbiology laboratories. Moreover, costs per sample and turnaround time from specimen receipt to clinical management continue to decrease, making the prospect of CMg more feasible. Many difficulties, however, are associated with CMg and warrant further improvements such as the informatics infrastructure and analytical pipelines. Thus, the current review focuses on comprehensively assessing applications of CMg for diagnostic and subtyping purposes.

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

“…• Adopt next-generation sequencing (NGS) and meta genomics approaches that allow unbiased pathogen detection 64…”

Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producingEnterobacter hormaechei

“…Metagenomic sequencing does, however, have certain limitations when considering its implementation in routine infection control, including the necessity for a reasonable amount of starting DNA, and the chance of amplification inhibition during library preparation (causing low yield or failed sequencing). Metagenomic sequencing can also be quite costly 42 , as the sequencing output needs to be sufficiently high to provide an accurate population structure and detect low-abundance organisms. In our study, while metagenomic sequencing of the environmental samples yielded positive results, it is still unclear how these reservoirs are causing reinfection in patients.…”

Shotgun-Metagenomics on Positive Blood Culture Bottles Inoculated With Prosthetic Joint Tissue: A Proof of Concept Study

“…Metagenomic next-generation sequencing (mNGS) refers to shotgun sequencing of all available DNA and/or RNA in a sample followed by the precise taxonomic identification and classification of each sequence (Couto et al, 2018;Rutanga et al, 2018). The application of shotgun metagenomics (SMg) to clinical samples to recover information of clinical relevance is emerging and it is known as clinical metagenomics (Forbes et al, 2018).…”